IVD MEDICAL (01931) announced that the company has resolved to proceed with a proposed dual primary listing on the US NASDAQ Stock Market through a proposed initial public offering of American Depositary Shares representing new ordinary shares to be issued by the company. On September 29, 2025 (US Eastern Time), the company confidentially submitted a draft F-1 registration statement to the US Securities and Exchange Commission regarding the proposed offering.

This proposed US dual listing represents an important initiative in the group's global strategic expansion, and is expected to bring positive impacts across multiple dimensions:

• Expanding Global Financing Channels: Entry into one of the world's largest and most liquid capital markets is expected to attract more international long-term investors focused on biotechnology and healthcare sectors, providing strong capital support for the company's subsequent research and development and commercialization efforts.

• Enhancing International Brand Influence: Listing on NASDAQ will further elevate the company's corporate image and industry recognition in international markets, strengthening communication and collaboration opportunities with global potential partners, customers, and regulatory authorities.

• Improving Share Liquidity and Valuation Potential: By establishing cross-market trading mechanisms, this will help expand the investor base, enhance overall share liquidity, and fully reflect the company's long-term value in a more internationalized pricing environment.

• Optimizing Corporate Governance and Transparency: Compliance with US securities regulations and disclosure requirements will further enhance the company's governance standards and operational transparency, strengthening the company's compliance image and investor trust globally.

• Providing Flexibility for Future Strategic Advancement: The dual listing structure provides a richer capital operation platform and strategic options for the company's potential future international cooperation, mergers and acquisitions, and business expansion.